SCHEMBL20945003

SCHEMBL20945003

CC(C)(C)OC(=O)NNC(=O)c1ccc(Cl)c(N2C(=O)C=CC2=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 4/20 0.56
▸ KMT2A Q03164 4/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ PKM P14618 3/20 0.56
▸ CCR6 P51684 3/20 0.56
▸ NPSR1 Q6W5P4 3/20 0.56
▸ APOBEC3G Q9HC16 3/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ G6PD P11413 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ LMNA P02545 1/20 0.56
▸ ALOX12 P18054 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ STAT3 P40763 1/20 0.38
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19480552 0.83 ALDH1A1 (0.38) HSP90AA1KMT2AALDH1A1PKMCCR6
SCHEMBL19480556 0.80 DDAH1 (0.47) HSP90AA1KMT2AALDH1A1PKMNPSR1
SCHEMBL20945305 0.76 ALDH1A1 (0.47) HSP90AA1KMT2AALDH1A1PKMCCR6
SCHEMBL19899991 0.73 POLB (0.65) KMT2AALDH1A1MEN1LMNAALOX12
SCHEMBL20945174 0.72 ALDH1A1 (0.58) HSP90AA1KMT2AALDH1A1PKMCCR6
SCHEMBL15146240 0.71 MEN1 (0.56) KMT2AALDH1A1PKMMEN1HPGD
SCHEMBL10737324 0.71 HDAC6 (0.50) GAAPOLBMAPTL3MBTL1
SCHEMBL1477613 0.70 MIF (0.50) KMT2AALDH1A1MEN1TDP1CYP3A4
SCHEMBL17172491 0.69 ALDH1A1 (0.66) KMT2AALDH1A1CCR6HTTTDP1
SCHEMBL13605085 0.69 MAPT (0.63) KMT2AALDH1A1MEN1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210002222-A1 AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS 3R VALO, S.E.C. (CA) 2021-01-07 — — US disclosed
EP-3442943-B1 AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS 3R VALO S E C (CA) 2020-10-07 — — EP disclosed
US-10759754-B2 Aminobenzoic acid derivatives for use as anti-inflammatory agents, anti-metastatic agents and/or anticancer agents 3R VALO, S.E.C. (CA) 2020-09-01 — — US disclosed
US-20190127325-A1 AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS UNIVERSITÉ DU QUÉBEC À TROIS-RIVIÈRES (CA) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002222-A1 AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS NFKBIA, NFKB1, NFRKB HSP90AA1 510/4885KMT2A 2071/4885ALDH1A1 324/4885
US-20190127325-A1 AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS NFKBIA, NFKB1, NFRKB HSP90AA1 510/4885KMT2A 2071/4885ALDH1A1 324/4885
US-10759754-B2 Aminobenzoic acid derivatives for use as anti-inflammatory agents, anti-metastatic agents and/or anticancer agents NFKBIA, NFKB1, NFRKB HSP90AA1 510/4885KMT2A 2071/4885ALDH1A1 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback